GRAL GRAIL, Inc.

$76.23▼ -1.71% Healthcare Other
After hours $76.23▲ +0.00% Sep 11, 7:30 PM ET
Volume 360.9K Avg Volume (10D) 580.9K
Key Metrics & Fundamentals
Market Cap
$3.40B
P/E Ratio
–
Div Yield
–%
52W Range
36.87 - 118.84
% vs 50 MA
4.04%
% vs 200 MA
4.43%
RSI-14
49.9
MACD Histogram
-0.6200
Beta (1Y vs SPY)
2.58
Free Cash Flow
-$81.16M
Gross Rev
$44.69M
Gross Profit
-$12.57M
EBITDA
-$84.25M
COGS
$57.25M
Operating Exp
$135.79M
Operating Income
-$148.36M
EBIT
-$148.36M
Pretax Income
-$166.71M
Net Income
-$110.25M
EPS (Diluted)
-2.56
Price & Volume History
Loading chart…
Recent News
UBS Initiates Coverage on GRAIL With Buy Rating, $105 Price Target
MT Newswires · Sep 9, 2026 12:22 PM
Grail CFO Aaron Freidin Sells 7,900 Shares for $672,000
Motley Fool · Sep 9, 2026 3:15 AM
Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test
Motley Fool · Sep 4, 2026 12:10 PM
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire · Sep 3, 2026 8:02 PM
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
PR Newswire · Aug 31, 2026 8:01 PM
GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting
MarketBeat · Aug 14, 2026 7:04 AM
GRAIL (GRAL) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 1:32 PM
Is GRAIL (GRAL) Fairly Valued Following Galleri Adoption Growth And The FDA Panel Date?
Simply Wall St. · Aug 8, 2026 5:12 AM
GRAIL's Galleri Blood Test to Be Evaluated by US FDA Advisory Panel
MT Newswires · Aug 7, 2026 7:57 PM
GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
PR Newswire · Aug 7, 2026 3:05 PM
Financial Overview - Income Statement Quarterly

See GRAL's money flow as a full page

Social Sentiment
Avg +0.72 · 5 posts
DDNewsDiscussion$GRAL - Cancer Detection to Skyrocket, FDA approvals & Insurance Reimbursement Catalysts Incoming
r/wallstreetbets · Dec 23, 2025
The post expresses strong bullish sentiment about GRAL, citing catalysts like FDA approvals and reimbursement.
very_positive +0.90
DDNewsDiscussionGRAIL ($GRAL) - Early cancer detection to grow in tens of multiples
r/investing · Dec 23, 2025
The post expresses strong optimism about GRAL's potential and growth prospects.
very_positive +0.80
TradeDiscussionAll in on GRAL!
r/wallstreetbets · Feb 21, 2025
The user's enthusiasm and stated position suggest a positive sentiment towards the stock.
positive +0.60
NewsDiscussionDDGrail (GRAL) and the Future of Early Cancer Detection: A Data-Driven Perspective
r/wallstreetbets · Feb 17, 2025
The discussion focuses on the positive aspects of Grail's technology and potential impact.
positive +0.70
Grail (GRAL) and the Future of Early Cancer Detection: A Data-Driven Perspective
r/stocks · Feb 17, 2025
The post highlights growth, potential, and a positive user experience, suggesting an optimistic outlook for the stock.
positive +0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙